Literature DB >> 24500190

Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants.

Jordan Meyers1, Eric Ryndock2, Michael J Conway2, Craig Meyers3, Richard Robison1.   

Abstract

OBJECTIVES: Little to nothing is known about human papillomavirus (HPV) susceptibility to disinfection. HPV is estimated to be among the most common sexually transmitted diseases in humans. HPV is also the causative agent of cervical cancers and other anogenital cancers and is responsible for a significant portion of oropharyngeal cancers. While sexual transmission is well documented, vertical and non-sexual transmission may also be important.
METHODS: Using recombinant HPV16 particles (quasivirions) and authentic HPV16 grown in three-dimensional organotypic human epithelial culture, we tested the susceptibility of high-risk HPV to clinical disinfectants. Infectious viral particles were incubated with 11 common clinical disinfectants, appropriate neutralizers were added to inactivate the disinfectant and solutions were filter centrifuged. Changes in the infectivity titres of the disinfectant-treated virus were measured compared with untreated virus.
RESULTS: HPV16 is a highly resistant virus; more so than other non-enveloped viruses previously tested. The HPV16 quasivirions showed similar resistance to native virions, except for being susceptible to isopropanol, the triple phenolic and the lower concentration peracetic acid-silver (PAA-silver)-based disinfectant. Authentic virus and quasivirus were resistant to glutaraldehyde and ortho-phthalaldehyde and susceptible to hypochlorite and the higher concentration PAA-silver-based disinfectant.
CONCLUSIONS: We present the first disinfectant susceptibility data on HPV16 native virions, which show that commonly used clinical disinfectants, including those used as sterilants in medical and dental healthcare facilities, have no effect on HPV16 infectivity. Policy changes concerning disinfectant use are needed. The unusually high resistance of HPV16 to disinfection supports other data suggesting the possibility of fomite or non-sexual transmission of HPV16.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cancer; glutaraldehydes; hospital sterilants; ortho-phthalaldehydes; papillomavirus

Mesh:

Substances:

Year:  2014        PMID: 24500190      PMCID: PMC4019329          DOI: 10.1093/jac/dku006

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Subunit interactions in bovine papillomavirus.

Authors:  Matthias Wolf; Robert L Garcea; Nikolaus Grigorieff; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

2.  Detection of human papillomavirus DNA on the fingers of patients with genital warts.

Authors:  C Sonnex; S Strauss; J J Gray
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

3.  Detection of genital HPV types in fingertip samples from newly sexually active female university students.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

4.  Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system.

Authors:  R J Visalli; R J Courtney; C Meyers
Journal:  Virology       Date:  1997-04-14       Impact factor: 3.616

5.  Is genital human papillomavirus infection always sexually transmitted?

Authors:  S K Tay; T H Ho; S K Lim-Tan
Journal:  Aust N Z J Obstet Gynaecol       Date:  1990-08       Impact factor: 2.100

6.  High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse).

Authors:  S K Kjaer; B Chackerian; A J van den Brule; E I Svare; G Paull; J M Walbomers; J T Schiller; J E Bock; M E Sherman; D R Lowy; C L Meijer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

7.  Evidence for vertical transmission of HPV from mothers to infants.

Authors:  Elaine M Smith; Michael A Parker; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Infect Dis Obstet Gynecol       Date:  2010-03-14

8.  Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein.

Authors:  Martine Chambon; Christine Archimbaud; Jean-Luc Bailly; Jeanne-Marie Gourgand; Françoise Charbonné; Hélène Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

9.  Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines.

Authors:  Michael J Conway; Samina Alam; Neil D Christensen; Craig Meyers
Journal:  Virology       Date:  2009-09-05       Impact factor: 3.616

10.  Efficacy of chemical treatments against murine norovirus, feline calicivirus, and MS2 bacteriophage.

Authors:  Doris H D'Souza; Xiaowei Su
Journal:  Foodborne Pathog Dis       Date:  2010-03       Impact factor: 3.171

View more
  19 in total

1.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

2.  Advancing infection control in Australasian medical ultrasound practice.

Authors:  Susan Campbell Westerway; Jocelyne M Basseal
Journal:  Australas J Ultrasound Med       Date:  2017-02-23

3.  Investigation of the Presence of DNA of Highly Pathogenic Human Papillomaviruses in Water Bodies of the Lake Baikal Natural Territory.

Authors:  A S Stolbikov; R K Salyaev; V N Nurminsky; M Yu Chernyshov
Journal:  Food Environ Virol       Date:  2022-08-06       Impact factor: 4.034

Review 4.  Human papilloma virions in the laboratory.

Authors:  Eileen F Dunne; Lauri E Markowitz; La'shan D Taylor; Elizabeth R Unger; Cosette M Wheeler
Journal:  J Clin Virol       Date:  2014-06-23       Impact factor: 3.168

5.  Non-invasive saliva-based screening of high-risk Human Papilloma Virus 16 and 18 in healthy young adults and creating awareness about its vaccination.

Authors:  Bandana Kumari; Asgar Ali; Abhay K Sharma; Aishwarya Gehlot; Sadhana Sharma
Journal:  J Family Med Prim Care       Date:  2021-01-30

6.  The importance of infection prevention and control in medical ultrasound.

Authors:  Lia Moshkanbaryans; Craig Meyers; Andrew Ngu; Jon Burdach
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

7.  Susceptibility of HPV16 and 18 to high level disinfectants indicated for semi-critical ultrasound probes.

Authors:  Eric Ryndock; Richard Robison; Craig Meyers
Journal:  J Med Virol       Date:  2015-11-13       Impact factor: 2.327

8.  Infection prevention and ultrasound probe decontamination practices in Europe: a survey of the European Society of Radiology.

Authors:  Christiane Marita Nyhsen; Hilary Humphreys; Carlos Nicolau; Gerhard Mostbeck; Michel Claudon
Journal:  Insights Imaging       Date:  2016-10-24

9.  Virucidal efficacy of a sonicated hydrogen peroxide system (trophon® EPR) following European and German test methods.

Authors:  Britta Becker; Birte Bischoff; Florian H H Brill; Eike Steinmann; Jochen Steinmann
Journal:  GMS Hyg Infect Control       Date:  2017-01-19

Review 10.  Papillomavirus Infectious Pathways: A Comparison of Systems.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  Viruses       Date:  2015-08-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.